These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 33169541)
1. Diversity of molecular targets and signaling pathways for CBD. de Almeida DL; Devi LA Pharmacol Res Perspect; 2020 Dec; 8(6):e00682. PubMed ID: 33169541 [TBL] [Abstract][Full Text] [Related]
2. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors. Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692 [TBL] [Abstract][Full Text] [Related]
3. Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT Galaj E; Bi GH; Yang HJ; Xi ZX Neuropharmacology; 2020 May; 167():107740. PubMed ID: 31437433 [TBL] [Abstract][Full Text] [Related]
4. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons. Straiker A; Dvorakova M; Zimmowitch A; Mackie K Mol Pharmacol; 2018 Jul; 94(1):743-748. PubMed ID: 29669714 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro. Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991 [TBL] [Abstract][Full Text] [Related]
7. Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB Bouma J; Broekhuis JD; van der Horst C; Kumar P; Ligresti A; van der Stelt M; Heitman LH Biochem Pharmacol; 2023 Dec; 218():115924. PubMed ID: 37972874 [TBL] [Abstract][Full Text] [Related]
8. Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals. Galaj E; Xi ZX Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374481 [TBL] [Abstract][Full Text] [Related]
12. Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice. Myers AM; Siegele PB; Foss JD; Tuma RF; Ward SJ Br J Pharmacol; 2019 May; 176(10):1552-1567. PubMed ID: 29338068 [TBL] [Abstract][Full Text] [Related]
13. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Campos AC; Moreira FA; Gomes FV; Del Bel EA; Guimarães FS Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3364-78. PubMed ID: 23108553 [TBL] [Abstract][Full Text] [Related]
14. Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review. Dos Santos RG; Hallak JEC; Crippa JAS Adv Exp Med Biol; 2021; 1264():29-45. PubMed ID: 33332002 [TBL] [Abstract][Full Text] [Related]
15. Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research. Melas PA; Scherma M; Fratta W; Cifani C; Fadda P Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668469 [TBL] [Abstract][Full Text] [Related]
16. Cannabis for the Treatment of Epilepsy: an Update. Gaston TE; Szaflarski JP Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563 [TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors. Sartim AG; Guimarães FS; Joca SR Behav Brain Res; 2016 Apr; 303():218-27. PubMed ID: 26801828 [TBL] [Abstract][Full Text] [Related]
18. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. McPartland JM; Duncan M; Di Marzo V; Pertwee RG Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544 [TBL] [Abstract][Full Text] [Related]
19. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Pertwee RG Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291 [TBL] [Abstract][Full Text] [Related]
20. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]